Brad Perkins

Board of Director
Oxstem
Albania

Business Expert Microbiology
Biography

Dr Brad Perkins is the Chief Medical Officer of Human Longevity Inc (HLI). Brad is a visionary physician, scientist, and executive who leads all clinical and therapeutic operations at HLI. Brad was previously Executive Vice President for Strategy and Innovation, and Chief Transformation Officer at Vanguard Health Systems. He began his career at the Centers for Disease Control and Prevention (CDC) after completing his residency training and chief residency in internal medicine at Baylor College of Medicine. He led the Meningitis and Special Pathogens Branch at the CDC where he investigated global bacterial disease epidemics. In 2001 Dr Perkins led the investigations into the anthrax attacks in the United States, the largest and highest profile investigation ever conducted by CDC. In 2005 he was appointed CDC’s Chief Strategy and Innovation Officer, a position in which he managed a $11.2 billion budget, and 15,000 employees with offices in more than 50 countries. Working closely with the CDC Director, he built a $2 billion state-of-the-art emergency response capability and positioned the improvement of population health as a focus of the healthcare reform movement within the White House administration at that time. Dr Brad Perkins is the Chief Medical Officer of Human Longevity Inc (HLI). Brad is a visionary physician, scientist, and executive who leads all clinical and therapeutic operations at HLI. Brad was previously Executive Vice President for Strategy and Innovation, and Chief Transformation Officer at Vanguard Health Systems. He began his career at the Centers for Disease Control and Prevention (CDC) after completing his residency training and chief residency in internal medicine at Baylor College of Medicine. He led the Meningitis and Special Pathogens Branch at the CDC where he investigated global bacterial disease epidemics. In 2001 Dr Perkins led the investigations into the anthrax attacks in the United States, the largest and highest profile investigation ever conducted by CDC. In 2005 he was appointed CDC’s Chief Strategy and Innovation Officer, a position in which he managed a $11.2 billion budget, and 15,000 employees with offices in more than 50 countries. Working closely with the CDC Director, he built a $2 billion state-of-the-art emergency response capability and positioned the improvement of population health as a focus of the healthcare reform movement within the White House administration at that time.

Research Intrest

fermentation